Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises UBS in connection with base prospectus regarding certificates and warrants
Mandate

Vinge advises UBS in connection with base prospectus regarding certificates and warrants

August 28, 2013

Vinge has advised UBS Deutschland AG in connection with the preparation of a three part base prospectus for structured products which will consist of various types of certificates and warrants. The structured products will primarily be traded on NASDAQ OMX Stockholm and possibly other Nordic exchanges. The base prospectus was approved by the Swedish Financial Supervisory Authority on 16 August 2013.

Vinge’s team consisted of responsible partner Anders Strid and lawyer Yohanna Öhrnegård.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025